Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (12) , 3678-3685
Abstract
Background: A number of plasma methylated DNA biomarkers related to colorectal cancer (CRC) have been identified. However, the effect of methylation level in leukocytes on plasma-based methylation test was rarely reported.Keywords
This publication has 23 references indexed in Scilit:
- DNA Methylation in Cancer and AgingCancer Research, 2016
- Validation of a Real-Time PCR–Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human PlasmaClinical Chemistry, 2014
- Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21BMC Medical Genomics, 2014
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?Cancer Research, 2013
- Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal CancerThe Journal of Molecular Diagnostics, 2013
- Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerGut, 2013
- DNA Methylation in Peripheral Blood: A Potential Biomarker for Cancer Molecular EpidemiologyJournal of Epidemiology, 2012
- Genomic Methylation of Leukocyte DNA in Relation to Colorectal Adenoma Among Asymptomatic WomenGastroenterology, 2008
- The Advanced Adenoma as the Primary Target of ScreeningGastrointestinal Endoscopy Clinics of North America, 2002